SAFETY AND EFFICCACY OF PLASMID MEDIATED THROMBOPOIETIN GENE THERAPY IN THE TREATMENT OF THROMBOCYTOPENIA SECONDARY TO CHRONIC LIVER DISEASE
Khalid Hassan El-Sherif;
Abstract
Thrombocytopenia is a common complication in patients with chronic liver disease, it occurs in about 76% in cirrhotic patients.
Thrombocytopenia secondary to chronic liver disease is mainly due to; Thrombopoiein deficiency, hypersplenism, bone marrow s
Thrombocytopenia secondary to chronic liver disease is mainly due to; Thrombopoiein deficiency, hypersplenism, bone marrow s
Other data
| Title | SAFETY AND EFFICCACY OF PLASMID MEDIATED THROMBOPOIETIN GENE THERAPY IN THE TREATMENT OF THROMBOCYTOPENIA SECONDARY TO CHRONIC LIVER DISEASE | Other Titles | علاج نقص الصفائح الدموية الناتج عن أمراض الكبد المزمنة عن طريق حقن جين الثرومبوبويكين | Authors | Khalid Hassan El-Sherif | Keywords | SAFETY AND EFFICCACY OF PLASMID MEDIATED THROMBOPOIETIN GENE THERAPY IN THE TREATMENT OF THROMBOCYTOPENIA SECONDARY TO CHRONIC LIVER DISEASE | Issue Date | 2010 | Description | Thrombocytopenia is a common complication in patients with chronic liver disease, it occurs in about 76% in cirrhotic patients. Thrombocytopenia secondary to chronic liver disease is mainly due to; Thrombopoiein deficiency, hypersplenism, bone marrow s |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 96919r3188.pdf | 96.87 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.